Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Claus B. Andersen is active.

Publication


Featured researches published by Claus B. Andersen.


Pediatric Pulmonology | 2009

Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients

Thomas Bjarnsholt; Peter Østrup Jensen; Mark J. Fiandaca; Jette Pedersen; C.R. Hansen; Claus B. Andersen; Tacjana Pressler; Michael Givskov; Niels Høiby

The present study was undertaken to investigate the appearance and location of Pseudomonas aeruginosa in the cystic fibrosis (CF) lung and in sputum. Samples include preserved tissues of CF patients who died due to chronic P. aeruginosa lung infection prior to the advent of intensive antibiotic therapy, explanted lungs from 3 intensively treated chronically P. aeruginosa infected CF patients and routine sputum from 77 chronically P. aeruginosa infected CF patients. All samples were investigated microscopically using hematoxylin–eosin (HE), Gram and alcian‐blue stain, PNA FISH and immunofluorescence for alginate.


Nature Genetics | 1999

A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor

Lars Madsen; Ellen Christina Andersson; Liselotte Jansson; Michelle Krogsgaard; Claus B. Andersen; Jan Engberg; Jack L. Strominger; Arne Svejgaard; Jens Hjorth; Rikard Holmdahl; Kai W. Wucherpfennig; Lars Fugger

Multiple sclerosis (MS) is a complex chronic neurologic disease with a suspected autoimmune pathogenesis. Although there is evidence that the development of MS is determined by both environmental influences and genes, these factors are largely undefined, except for major histocompatibility (MHC) genes. Linkage analyses and association studies have shown that susceptibility to MS is associated with genes in the human histocompatibility leukocyte antigens (HLA) class II region, but the contribution of these genes to MS disease development is less compared with their contribution to disorders such as insulin-dependent diabetes mellitus. Due to the strong linkage disequilibrium in the MHC class II region, it has not been possible to determine which gene(s) is responsible for the genetic predisposition. In transgenic mice, we have expressed three human components involved in T-cell recognition of an MS-relevant autoantigen presented by the HLA-DR2 molecule: DRA*0101/DRB1*1501 (HLA-DR2), an MHC class II candidate MS susceptibility genes found in individuals of European descent; a T-cell receptor (TCR) from an MS-patient-derived T-cell clone specific for the HLA-DR2 bound immunodominant myelin basic protein (MBP) 84–102 peptide; and the human CD4 coreceptor. The amino acid sequence of the MBP 84–102 peptide is the same in both human and mouse MBP. Following administration of the MBP peptide, together with adjuvant and pertussis toxin, transgenic mice developed focal CNS inflammation and demyelination that led to clinical manifestations and disease courses resembling those seen in MS. Spontaneous disease was observed in 4% of mice. When DR2 and TCR double-transgenic mice were backcrossed twice to Rag2 (for recombination-activating gene 2)-deficient mice, the incidence of spontaneous disease increased, demonstrating that T cells specific for the HLA-DR2 bound MBP peptide are sufficient and necessary for development of disease. Our study provides evidence that HLA-DR2 can mediate both induced and spontaneous disease resembling MS by presenting an MBP self-peptide to T cells.


Journal of Heart and Lung Transplantation | 2013

The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation

Gerald J. Berry; Margaret Burke; Claus B. Andersen; Patrick Bruneval; Marny Fedrigo; Michael C. Fishbein; Martin Goddard; Elizabeth H. Hammond; Ornella Leone; Charles C. Marboe; Dylan V. Miller; Desley Neil; Doris Rassl; Monica P. Revelo; Alexandra Rice; E. Rene Rodriguez; Susan Stewart; Carmela D. Tan; Gayle L. Winters; Lori J. West; Mandeep R. Mehra; Annalisa Angelini

During the last 25 years, antibody-mediated rejection of the cardiac allograft has evolved from a relatively obscure concept to a recognized clinical complication in the management of heart transplant patients. Herein we report the consensus findings from a series of meetings held between 2010-2012 to develop a Working Formulation for the pathologic diagnosis, grading, and reporting of cardiac antibody-mediated rejection. The diagnostic criteria for its morphologic and immunopathologic components are enumerated, illustrated, and described in detail. Numerous challenges and unresolved clinical, immunologic, and pathologic questions remain to which a Working Formulation may facilitate answers.


Optics Express | 2004

Determination of optical scattering properties of highly-scattering media in optical coherence tomography images

David Levitz; Lars Thrane; Michael H. Frosz; Peter E. Andersen; Claus B. Andersen; Jurga Valanciunaite; Johannes Swartling; Stefan Andersson-Engels; Peter Riis Hansen

We developed a new algorithm that fits optical coherence tomography (OCT) signals as a function of depth to a general theoretical OCT model which takes into account multiple scattering effects. With use of this algorithm, it was possible to extract both the scattering coefficient and anisotropy factor from a particular region of interest in an OCT image. The extraction algorithm was evaluated against measurements from an integrating sphere on a set of tissue phantoms and yielded valid results. Finally, a preliminary ex vivo OCT investigation on human aortic specimen indicated that the algorithm may contribute importantly to differentiation between normal and atherosclerotic arteries. We conclude that this algorithm may facilitate tissue characterization by OCT.


Journal of The American Society of Nephrology | 2003

Chronic Renal Failure Accelerates Atherogenesis in Apolipoprotein E–Deficient Mice

Susanne Bro; Jacob F. Bentzon; Erling Falk; Claus B. Andersen; Klaus Olgaard; Lars B. Nielsen

Cardiovascular mortality is 10 to 20 times increased in patients with chronic renal failure (CRF). Risk factors for atherosclerosis are abundant in patients with CRF. However, the pathogenesis of cardiovascular disease in CRF remains to be elucidated. The effect of CRF on the development of atherosclerosis in apolipoprotein E-deficient male mice was examined. Seven-week-old mice underwent 5/6 nephrectomy (CRF, n = 28), unilateral nephrectomy (UNX, n = 24), or no surgery (n = 23). Twenty-two weeks later, CRF mice showed increased aortic plaque area fraction (0.266 +/- 0.033 versus 0.045 +/- 0.006; P < 0.001), aortic cholesterol content (535 +/- 62 versus 100 +/- 9 nmol/cm(2) intimal surface area; P < 0.001), and aortic root plaque area (205,296 +/- 22,098 versus 143,662 +/- 13,302 micro m(2); P < 0.05) as compared with no-surgery mice; UNX mice showed intermediate values. The plaques from uremic mice contained CD11b-positive macrophages and showed strong staining for nitrotyrosine. Systolic BP and plasma homocysteine concentrations were similar in uremic and nonuremic mice. Plasma urea and cholesterol concentrations were elevated 2.6-fold (P < 0.001) and 1.5-fold (P < 0.001) in CRF compared with no-surgery mice. Both variables correlated with aortic plaque area fraction (r(2) = 0.5, P < 0.001 and r(2) = 0.3, P < 0.001, respectively) and with each other (r(2) = 0.5, P < 0.001). On multiple linear regression analysis, only plasma urea was a significant predictor of aortic plaque area fraction. In conclusion, the present findings suggest that uremia markedly accelerates atherogenesis in apolipoprotein E-deficient mice. This effect could not be fully explained by changes in BP, plasma homocysteine levels, or total plasma cholesterol concentrations. Thus, the CRF apolipoprotein E-deficient mouse is a new model for studying the pathogenesis of accelerated atherosclerosis in uremia.


Journal of Assisted Reproduction and Genetics | 2012

Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer

S. Samuel Kim; Jacques Donnez; Pedro N. Barri; A. Pellicer; Pasquale Patrizio; Z. Rosenwaks; Peter Nagy; Tommaso Falcone; Claus B. Andersen; Outi Hovatta; Hamish Wallace; Dror Meirow; Debra A. Gook; Seok Hyung Kim; Chii Ruey Tzeng; Shuetu Suzuki; Bunpei Ishizuka; Marie-Madeleine Dolmans

Fertility issues should be addressed to all patients in reproductive age before cancer treatment. In men, cryopreservation of sperm should be offered to all cancer patients in reproductive age regardless of the risk of gonadal failure. In women, the recommendation of fertility preservation should be individualized based on multiple factors such as the urgency of treatment, the age of the patient, the marital status, the regimen and dosage of cancer treatment.


Journal of Biological Chemistry | 2004

Human Placenta Secretes Apolipoprotein B-100-containing Lipoproteins

Eva M. Madsen; Marie L. S. Lindegaard; Claus B. Andersen; Peter Damm; Lars B. Nielsen

Supply of lipids from the mother is essential for fetal growth and development. In mice, disruption of yolk sac cell secretion of apolipoprotein (apo) B-containing lipoproteins results in embryonic lethality. In humans, the yolk sac is vestigial. Nutritional functions are instead established very early during pregnancy in the placenta. To examine whether the human placenta produces lipoproteins, we examined apoB and microsomal triglyceride transfer protein (MTP) mRNA expression in placental biopsies. ApoB and MTP are mandatory for assembly and secretion of apoB-containing lipoproteins. Both genes were expressed in placenta and microsomal extracts from human placenta contained triglyceride transfer activity, indicating expression of bioactive MTP. To detect lipoprotein secretion, biopsies from term placentas were placed in medium with [35S]methionine and [35S]cysteine for 3–24 h. Upon sucrose gradient ultracentrifugation of the labeled medium, fractions were analyzed by apoB-immunoprecipitation. 35S-labeled apoB-100 was recovered in d ∼1.02–1.04 g/ml particles (i.e. similar to the density of plasma low density lipoproteins). Electron microscopy of negatively stained lipoproteins secreted from placental tissue showed spherical particles with a diameter of 47 ± 10 nm. These results demonstrate that human placenta expresses both apoB and MTP and consequently synthesize and secrete apoB-100-containing lipoproteins. Placental lipoprotein formation constitutes a novel pathway of lipid transfer from the mother to the developing fetus.


Regulatory Peptides | 2006

Apelin : A new plasma marker of cardiopulmonary disease

Jens Peter Goetze; Jens F. Rehfeld; Jørn Carlsen; Regitze Videbæk; Claus B. Andersen; Soeren Boesgaard; Lennart Friis-Hansen

OBJECTIVES Dyspnea is a major symptom of both parenchymal lung disease and chronic heart failure. Underlying cardiac dysfunction can be assessed by measurement of cardiac-derived B-type natriuretic peptide or its precursor in plasma. However, no specific endocrine marker of the lung parenchyma has so far been identified. We therefore examined whether plasma concentrations of apelin, a novel inotropic hormone, is affected in patients with chronic parenchymal lung disease without cardiac dysfunction. METHODS AND RESULTS Patients with severe chronic parenchymal lung disease and normal cardiac function (n=53), idiopathic pulmonary hypertension with increased right ventricular pressure (n=10), and patients with severe left ventricular systolic dysfunction (n=22) were enrolled. Plasma apelin-36 and proBNP concentrations were measured with radioimmunoassays. While proBNP plasma concentrations were unaffected in chronic parenchymal lung disease patients compared to normal subjects, the apelin-36 concentration was reduced 3.3-fold (median 35 pmol/l (0-162 pmol/l) vs. 117 pmol/l (55-232 pmol/l), P<0.001). Moreover, the apelin-36 concentration was decreased in chronic heart failure patients (2.1-fold, P<0.01) and in patients with idiopathic pulmonary hypertension (4.0-fold, P<0.001). In contrast, the proBNP concentration was highly increased in both chronic heart failure and idiopathic pulmonary hypertension patients. CONCLUSION Plasma concentrations of apelin-36, a novel inotropic peptide, are decreased in patients with chronic parenchymal lung disease and preserved cardiac function. Combined measurement of apelin-36 and proBNP may be a new diagnostic approach in distinguishing pulmonary from cardiovascular causes of dyspnea.


Journal of Heart and Lung Transplantation | 2013

Pathology of pulmonary antibody-mediated rejection: 2012 update from the Pathology Council of the ISHLT

Gerald J. Berry; Margaret Burke; Claus B. Andersen; Annalisa Angelini; Patrick Bruneval; Fiorella Calbrese; Michael C. Fishbein; Martin Goddard; Ornella Leone; Joseph J. Maleszewski; Charles C. Marboe; Dylan V. Miller; Desley Neil; Robert F. Padera; Doris Rassi; Monica Revello; Alexandra Rice; Susan Stewart; Samuel A. Yousem

Gerald Berry, MD, Margaret Burke, FRCPath, Claus Andersen, MD, DMSc, Annalisa Angelini, MD, Patrick Bruneval, MD, Fiorella Calbrese, MD, Michael C. Fishbein, MD, Martin Goddard, FRCS, MRCPa, Ornella Leone, MD, Joseph Maleszewski, MD, Charles Marboe, MD, Dylan Miller, MD, Desley Neil, FRCPath, Robert Padera, MD, PhD, Doris Rassi, MBBS, MRCP, Monica Revello, MD, PhD, Alexandra Rice, FRCPath, Susan Stewart, FRCPath, and Samuel A Yousem, MD


Wound Repair and Regeneration | 2011

Quantitative analysis of the cellular inflammatory response against biofilm bacteria in chronic wounds.

Mustafa Fazli; Thomas Bjarnsholt; Klaus Kirketerp-Møller; Anne Jørgensen; Claus B. Andersen; Michael Givskov; Tim Tolker-Nielsen

Chronic wounds are an important problem worldwide. These wounds are characterized by a persistent inflammatory stage associated with excessive accumulation and elevated cell activity of neutrophils, suggesting that there must be a persistent stimulus that attracts and recruits neutrophils to the wound. One such stimulus might be the presence of bacterial biofilms in chronic wounds. In the present study, biopsy specimens from chronic venous leg ulcers were investigated for the detection of bacteria using peptide nucleic acid‐based fluorescence in situ hybridization (PNA‐FISH) and confocal laser scanning microscopy. The bacteria in the wounds were often situated in large aggregates. To obtain a measure of the cellular inflammatory response against the bacteria in the chronic wounds, the amount of neutrophils accumulated at the site of infection was evaluated through differential neutrophil counting on the tissue sections from wounds containing either Pseudomonas aeruginosa or Staphylococcus aureus. The P. aeruginosa‐containing wounds had significantly higher numbers of neutrophils accumulated compared with the S. aureus‐containing wounds. These results are discussed in relation to the hypothesis that the presence of P. aeruginosa biofilms in chronic wounds may be one of the main factors leading to a persistent inflammatory response and impaired wound healing.

Collaboration


Dive into the Claus B. Andersen's collaboration.

Top Co-Authors

Avatar

Jørn Carlsen

Copenhagen University Hospital

View shared research outputs
Top Co-Authors

Avatar

Martin Iversen

Copenhagen University Hospital

View shared research outputs
Top Co-Authors

Avatar

Christopher M. Burton

Copenhagen University Hospital

View shared research outputs
Top Co-Authors

Avatar

Nils Milman

Copenhagen University Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Maura D. Iversen

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar

Daniel A. Steinbrüchel

Copenhagen University Hospital

View shared research outputs
Top Co-Authors

Avatar

Finn Gustafsson

Copenhagen University Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Søren Boesgaard

Copenhagen University Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge